Earnings calendar

Ascendis Pharma A/S (ASND) earnings: date, estimates, results and stock reactions

Next earnings: Q1 FY2027 on 2027-02-10 (expected, before the open). EPS estimate 1.45, revenue estimate 504.1M.

Over the last 12 reports the stock moved 4.9% on average (either way), rising 7 times and falling 5. EPS beat estimates 7 of 12 times; revenue 7 of 12. Close before the report date to the first close after it (two trading sessions, covering before-the-open and after-the-close reports).

QuarterReportedEPSEPS estimateEPS surpriseRevenueRevenue estimateStock move
Q4 FY20262026-11-121.240.90+37.6%418.8M409.4M+6.2%
Q3 FY20262026-08-133.291.71+92.4%387.5M376.8M-2.7%
Q2 FY20262026-05-070.320.19+70.6%284.9M308.9M+1.2%
Q1 FY20262026-02-11-0.64-0.06-966.7%344.8M292.3M-2.7%
Q4 FY20252025-11-12-1.17-0.41-185.4%250.2M302.6M+2.6%
Q3 FY20252025-08-07-0.93-1.42+34.5%186.1M233.1M+4.9%
Q2 FY20252025-05-01-1.66-1.56-6.4%110.7M153.5M+1.0%
Q1 FY20252025-02-12-0.68-1.20+43.3%180.1M125.4M+19.2%

ASND stock report · Earnings calendar